home · filing · 0001522540-22-000043
8-K
filed September 14, 2022, 7:59 PM ET
ticker MQ
CIK 0001522540
leadership
confidence high
sentiment neutral
materiality 0.30
Marqeta board changes: director Amy Chang resigns; Kiran Prasad appointed
Marqeta, Inc.
Amy Chang resigned from the Board and Nomination and Governance Committee on Sept 14, 2022, with no disagreement.
Srikiran (Kiran) Prasad appointed as Class III director and to the Compensation Committee effective same day.
Prasad's compensation follows standard non-employee director policy; no family relationships or reportable transactions.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Srikiran (Kiran) Prasad
Class III Director
Effective 2022-09-14
Filed September 14, 2022, 7:59 PM ET
On September 14, 2022, the Board appointed Srikiran (Kiran) Prasad to serve as a Class III member of the Board.
Departed
Amy Chang
Director
Effective 2022-09-14
Filed September 14, 2022, 7:59 PM ET
On September 14, 2022, Amy Chang resigned as a member of the Board of Directors (the “Board”) of Marqeta, Inc. (the “Company”).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Srikiran (Kiran) Prasad was appointed as Class III Director at Marqeta, Inc..
Action appointed
Role Class III Director
Exact text from the filing
On September 14, 2022, the Board appointed Srikiran (Kiran) Prasad to serve as a Class III member of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Amy Chang resigned as Director at Marqeta, Inc..
Action resigned
Role Director
Exact text from the filing
On September 14, 2022, Amy Chang resigned as a member of the Board of Directors (the “Board”) of Marqeta, Inc. (the “Company”).
View on SEC.gov
Source: SEC EDGAR
accession 0001522540-22-000043
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.